Searched for
SRIRAAM RATHI
Double digit earnings growth for pharma in next 2 yrs; 4 stocks to bet on: Sriraam RathiThe pharma sector is set to experience double-digit earnings growth over the next couple of years, supporting valuations, according to Srir...- Rally in pharma stocks lifts benchmark indicesLong-term structural growth potential driven by anticipated shortage and price increases prompted investors to shuffle their bets in favour...
- Pharma stocks continue to underperform in 2023. Should investors take the bitter pill?The Nifty Pharma Index fell about 6% so far this year on a year-to-date basis. The price pressure in US generic market is seen as a key dra...
- Dispute settlement gives this stock an edge over peers in pharma packKunal Dhamesha of Emkay Global raised his price target for the stock to Rs 1,000 and sees potential gain of Rs 45 per share from the settle...
- Dr Reddy’s string of announcements fails to impress analysts; stock could fall 30%Kotak Securities has a ‘sell’ recommendation on the stock with the target at Rs 3,700, a potential downside of over 30 per cent from curren...
- Natco Pharma soars 17% as path to launch Revlimid generic clearsNatco Pharma would be the first company to launch Revlimid (lenalidomide) in March 2022 as Dr Reddy’s settlement clears the path for the co...
- JB Chemicals valuations attractive: AnalystsNPPA notified one-time price increase of 50 per cent from existing ceiling price of select 21 National List of Essential Medicines products.
- Outlook 2019: Pharma looks medically fit for double-digit growth after years of sufferingClearance in 483 observations indicates increased regulatory compliance by the companies.
- Shilpa Medicare on cusp on transition, hits 52-wk highThe stock hit a 52-week high of `700 on Wednesday after the company announced that it has received FDA nod for its generic cancer treatment...
- Shilpa Medicare on the cusp of transitionThe company has potential to throw many positive surprises on back of pipeline of work that it has done in past few years, according to ana...
Load More
